Cortexyme Bets on P. Gingivalis Toxin Disrupter to Slow Alzheimer’s Progression

Cortexyme isn’t letting a missed primary endpoint stifle its conviction that P. gingivalis, the bacteria that causes periodontal disease, is a root cause of Alzheimer’s disease (AD) and that its oral medication atuzaginstat can put the brakes on both cognitive and functional degeneration.
Source: Drug Industry Daily